| Kylie Smith, MSN-FNP | |
|
2880 Tricom St, North Charleston, SC 29406-9171 | |
| (843) 797-5050 | |
| (843) 797-3633 |
| Full Name | Kylie Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 2880 Tricom St, North Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144636192 | NPI | - | NPPES |
| NP5960 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trident Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arcis Healthcare Llc | 0042448748 | 30 |
News Archive
New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.
Medill Reports: "Unless federal legislation closes the Medicare coverage gap colloquially known as the 'doughnut hole,' seniors may opt for online drug imports to alleviate steep prescription costs. ... 'As seniors start falling into the doughnut hole, they are going online to find deals on prescription drugs, whether they're based in the U.S. or in other countries,' said Gabriel Levitt, vice president of PharmacyChecker.com LLC, a leader in the evaluation of online and mail-order pharmacies in both the U.S. and abroad.
Scientists from the Antibody and Vaccine group at the University of Southampton have discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular "switch".
Whether it's plankton exposed to parasites or people exposed to pathogens, a host's initial immune response plays an integral role in determining whether infection occurs and to what degree it spreads within a population, new University of Colorado Boulder research suggests.
The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and sponsored by QuantumLeap Healthcare Collaborative has graduated the first two drugs from its innovative, multidrug standing platform trial.
› Verified 8 days ago
| Entity Name | Arcis Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902246077 PECOS PAC ID: 0042448748 Enrollment ID: O20131231001317 |
News Archive
New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.
Medill Reports: "Unless federal legislation closes the Medicare coverage gap colloquially known as the 'doughnut hole,' seniors may opt for online drug imports to alleviate steep prescription costs. ... 'As seniors start falling into the doughnut hole, they are going online to find deals on prescription drugs, whether they're based in the U.S. or in other countries,' said Gabriel Levitt, vice president of PharmacyChecker.com LLC, a leader in the evaluation of online and mail-order pharmacies in both the U.S. and abroad.
Scientists from the Antibody and Vaccine group at the University of Southampton have discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular "switch".
Whether it's plankton exposed to parasites or people exposed to pathogens, a host's initial immune response plays an integral role in determining whether infection occurs and to what degree it spreads within a population, new University of Colorado Boulder research suggests.
The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and sponsored by QuantumLeap Healthcare Collaborative has graduated the first two drugs from its innovative, multidrug standing platform trial.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kylie Smith, MSN-FNP 2880 Tricom St, North Charleston, SC 29406-9171 Ph: (843) 797-5050 | Kylie Smith, MSN-FNP 2880 Tricom St, North Charleston, SC 29406-9171 Ph: (843) 797-5050 |
News Archive
New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.
Medill Reports: "Unless federal legislation closes the Medicare coverage gap colloquially known as the 'doughnut hole,' seniors may opt for online drug imports to alleviate steep prescription costs. ... 'As seniors start falling into the doughnut hole, they are going online to find deals on prescription drugs, whether they're based in the U.S. or in other countries,' said Gabriel Levitt, vice president of PharmacyChecker.com LLC, a leader in the evaluation of online and mail-order pharmacies in both the U.S. and abroad.
Scientists from the Antibody and Vaccine group at the University of Southampton have discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular "switch".
Whether it's plankton exposed to parasites or people exposed to pathogens, a host's initial immune response plays an integral role in determining whether infection occurs and to what degree it spreads within a population, new University of Colorado Boulder research suggests.
The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and sponsored by QuantumLeap Healthcare Collaborative has graduated the first two drugs from its innovative, multidrug standing platform trial.
› Verified 8 days ago
Mr. Richard Dale Brinson, MSN, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9330 Medical Plaza Dr, North Charleston, SC 29406 Phone: 843-847-4595 | |
Kimberly Lynn Rhoton, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4050 Bridge View Dr, Suite 500, Perimeter Center, North Charleston, SC 29405 Phone: 843-746-4030 | |
Whitney Naramore Huff, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4975 Lacross Rd Ste 110, North Charleston, SC 29406 Phone: 843-797-1941 Fax: 843-574-1698 | |
Mrs. Dodi Lynn Baum, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9267 Medical Plaza Dr Ste G, North Charleston, SC 29406 Phone: 843-797-3636 | |
Tina Withrow, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, North Charleston, SC 29406 Phone: 843-572-9211 Fax: 843-572-0457 | |
Hannah Dweikat, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4920 Ohear Ave Ste 101, North Charleston, SC 29405 Phone: 843-856-3784 | |
Madison Sheheane, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8471 Resolute Way Ste 102, North Charleston, SC 29420 Phone: 843-876-2879 |